Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer.
about
Androgens in pregnancy: roles in parturitionMolecular determinants of context-dependent progesterone receptor action in breast cancerIdentification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapiesDeciphering the divergent roles of progestogens in breast cancer.Androgen Receptor as a Potential Target for Treatment of Breast Cancer.The Role of Androgens in Normal and Malignant Breast Tissue.Androgen receptor genotypes predict response to endocrine treatment in breast cancer patients.Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effectsGender-medicine aspects in allergology.Medroxyprogesterone acetate differentially regulates interleukin (IL)-12 and IL-10 in a human ectocervical epithelial cell line in a glucocorticoid receptor (GR)-dependent mannerAnchoring junctions as drug targets: role in contraceptive development.Corepressor effect on androgen receptor activity varies with the length of the CAG encoded polyglutamine repeat and is dependent on receptor/corepressor ratio in prostate cancer cells.Prosaposin activates the androgen receptor and potentiates resistance to endocrine treatment in breast cancer.Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene?Expression of androgen receptor in breast cancer & its correlation with other steroid receptors & growth factorsFourth-Generation Progestins Inhibit 3β-Hydroxysteroid Dehydrogenase Type 2 and Modulate the Biosynthesis of Endogenous Steroids.Postmenopausal mammographic breast density and subsequent breast cancer risk according to selected tissue markers.Integration of progesterone receptor action with rapid signaling events in breast cancer models.1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene (p,p'-DDE) disrupts the estrogen-androgen balance regulating the growth of hormone-dependent breast cancer cells.Minireview: nuclear receptors and breast cancerEffects of maternal dietary exposure to cadmium during pregnancy on mammary cancer risk among female offspring.Review of the etiology of breast cancer with special attention to organochlorines as potential endocrine disruptors.Tamoxifen prevents premalignant changes of breast, but not ovarian, cancer in rats at high risk for both diseases.Role of the androgen receptor in triple-negative breast cancer.AR Signaling in Breast Cancer.Postmenopausal breast cancer, androgens, and aromatase inhibitors.Testosterone and risk of breast cancer: appraisal of existing evidence.Coexpression of androgen receptor and FOXA1 in nonmetastatic triple-negative breast cancer: ancillary study from PACS08 trial.Prognostic significance of androgen receptor expression in invasive breast cancer: transcriptomic and protein expression analysis.The activity of medroxyprogesterone acetate, an androgenic ligand, in ovarian cancer cell invasion.Cinical Significance of Androgen Receptor, CK-5/6, KI-67 and Molecular Subtypes in Breast Cancer.Loss of androgen receptor expression predicts early recurrence in triple-negative and basal-like breast cancer.Genetic variation in hormone metabolizing genes and risk of testicular germ cell tumors.Effects of the addition of methyltestosterone to combined hormone therapy with estrogens and progestogens on sexual energy and on orgasm in postmenopausal women.Systemic and local effects of vaginal dehydroepiandrosterone (DHEA): NCCTG N10C1 (Alliance).
P2860
Q26822669-FF9C74E9-9B75-474C-B656-060220F37739Q26997928-8F3B915B-B4D5-4FB6-88F9-5D81427A82B5Q29617680-AC65FB50-4B90-4D47-9905-CEBCDFD89357Q30240711-16918DC6-837C-47C4-80AD-5BDB2D2B20E6Q33625672-0596956E-B63A-4A67-9704-BF782AD279E7Q34096288-53149847-D520-48CA-AF92-A1B19943F407Q34228066-D8DBD55B-651E-49A5-9EDE-A5EDE6889EF5Q34317537-78735679-96E1-4700-A125-27C2E8F21DD0Q34394262-743CC9EA-4355-4FD7-A70E-AC9826F04091Q34467518-E1548772-8C10-4AE6-932D-9EAB3CD1AC52Q34501400-276DD524-F6A3-4400-89FF-3E054C5AF8CEQ35858203-49AB64D5-994C-4120-B8C9-7B2721E18629Q36030567-593AC070-5388-48A9-AD9C-D32C44111C5DQ36113793-0A1DB4B0-8FEC-4491-85A1-19B096DF3882Q36134487-CE70C909-B827-4FF1-A4FF-495AC4EAB74CQ36153866-99D3CC10-B549-42C3-9FA0-96376C87CCDBQ36295033-24CB3263-A474-4B1E-8698-69519A08D5B4Q36580735-A5E3493A-8B85-4C9D-B006-4DCD039B88A8Q36643095-72878642-D3A5-47DF-B3EF-6E4C6188163BQ36971797-7BBF32BA-261C-423E-92FF-2BD75E58273CQ37005915-0DF97685-FF18-4E5C-B5D4-DC44DC3EBA8CQ37119906-8BBC3A6D-493C-4602-BC6E-F7C4FB6ADE1DQ37357759-ABFD9727-8491-404D-897D-210997103AFFQ37573317-B6E09025-F1E3-4E57-9E67-9FF64B786E4BQ37721492-4764A8DF-FADC-4B09-83EC-481C07613436Q38097730-5EAF579C-A20D-4E32-9071-40B3E088442AQ38471436-573067EE-CEB2-48F3-962A-E8D613EC7E73Q38975595-B55BA188-0C8E-4723-8127-711E12775E5DQ39499250-EEF5512C-F7BC-4138-AD32-DCEC038777A9Q39914955-9099658F-C4D9-4D59-B2A0-4BB25CA42375Q42007131-6FD8C04C-FF1F-4739-B34A-3B94CADF6E9BQ42442829-F8853252-C2D7-4635-897E-0E1BB7302069Q46642326-D7471664-A4D4-4CCF-86F4-EC3FADBD26B3Q46802795-23A134BB-A848-40B8-97EB-78263157ADF1Q49822445-85C1B17B-D820-46A3-9847-AA4FD9E2AE90
P2860
Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Disruption of androgen recepto ...... k of developing breast cancer.
@en
type
label
Disruption of androgen recepto ...... k of developing breast cancer.
@en
prefLabel
Disruption of androgen recepto ...... k of developing breast cancer.
@en
P2093
P356
P1433
P1476
Disruption of androgen recepto ...... k of developing breast cancer.
@en
P2093
Grant Buchanan
Jonathan M Harris
Lisa M Butler
Stephen N Birrell
Wayne D Tilley
P304
P356
10.1096/FJ.06-7518COM
P407
P577
2007-04-05T00:00:00Z